ST3GAL4 and neoplasm: Tumor cells upregulate the sialyltransferase ST3Gal IV, leading to an increase in ST antigen that inhibits macrophage activation and promotes macrophage differentiation in tumor-associated macrophages, in combination with Siglec-9, thereby inducing the formation of an immunosuppressive microenvironment [71].